Critical Comparison: Charles River Laboratories International (NYSE:CRL) & Alpha Teknova (NASDAQ:TKNO)

Charles River Laboratories International (NYSE:CRL – Get Free Report) and Alpha Teknova (NASDAQ:TKNO – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends.

Insider and Institutional Ownership

98.9% of Charles River Laboratories International shares are owned by institutional investors. Comparatively, 13.8% of Alpha Teknova shares are owned by institutional investors. 1.3% of Charles River Laboratories International shares are owned by company insiders. Comparatively, 13.2% of Alpha Teknova shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Risk and Volatility

Charles River Laboratories International has a beta of 1.36, indicating that its stock price is 36% more volatile than the S&P 500. Comparatively, Alpha Teknova has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500.

Valuation & Earnings

This table compares Charles River Laboratories International and Alpha Teknova”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Charles River Laboratories International $4.02 billion 3.95 -$144.34 million $0.91 363.88
Alpha Teknova $40.52 million 12.04 -$17.26 million ($0.29) -26.74

Alpha Teknova has lower revenue, but higher earnings than Charles River Laboratories International. Alpha Teknova is trading at a lower price-to-earnings ratio than Charles River Laboratories International, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Charles River Laboratories International and Alpha Teknova’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Charles River Laboratories International 1.01% 16.95% 6.93%
Alpha Teknova -34.76% -24.95% -16.27%

Analyst Ratings

This is a summary of current recommendations for Charles River Laboratories International and Alpha Teknova, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Charles River Laboratories International 1 3 12 0 2.69
Alpha Teknova 1 1 4 0 2.50

Charles River Laboratories International currently has a consensus target price of $311.67, indicating a potential downside of 5.88%. Alpha Teknova has a consensus target price of $8.75, indicating a potential upside of 12.84%. Given Alpha Teknova’s higher possible upside, analysts clearly believe Alpha Teknova is more favorable than Charles River Laboratories International.

Summary

Charles River Laboratories International beats Alpha Teknova on 10 of the 14 factors compared between the two stocks.

About Charles River Laboratories International

(Get Free Report)

Charles River Laboratories International is a contract research organization that supports pharmaceutical and biotechnology companies, as well as academic and government researchers, in developing medicines and advancing scientific research. Its services span the drug development process, from early discovery and preclinical research to manufacturing support. The company’s offerings include research models and related services, drug discovery and safety assessment, and manufacturing solutions. These may include laboratory animal models, laboratory testing, bioanalysis, and support for the production of products used in the development of pharmaceuticals and biologics.

About Alpha Teknova

(Get Free Report)

Alpha Teknova, Inc. develops and manufactures reagents used in life science research and the development and production of biopharmaceuticals and diagnostic products. Its offerings include cell culture media, buffers, molecular biology reagents, proteins and other laboratory materials. The company provides both catalog products and custom reagent development and manufacturing services. Its customers include biotechnology and pharmaceutical companies, diagnostic developers, academic institutions and research laboratories.

Receive News & Ratings for Charles River Laboratories International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Charles River Laboratories International and related companies with MarketBeat.com's FREE daily email newsletter.